Acute and subacute toxicity associated with concurrent adjuvant radiation therapy and paclitaxel in primary breast cancer therapy

Breast Journal

Volumn 8, Issue 3, 2002, Pages 149-153

  Hanna, Youseff M ^a   Baglan, Kathleen L ^a   Stromberg, Jannifer S ^a   Vicini, Frank A ^a   Decker, David A ^a,b  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Breast cancer; Paclitaxel; Therapy; Toxicity

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; PACLITAXEL;

ADULT; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG INDUCED DISEASE; HOSPITALIZATION; HUMAN; LUNG TOXICITY; MASTECTOMY; OPEN LUNG BIOPSY; PARTIAL MASTECTOMY; RADIATION INJURY; RADIATION PNEUMONIA; SKIN TOXICITY; SURGICAL TECHNIQUE;

ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AXILLA; BREAST NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LYMPH NODE EXCISION; MASTECTOMY, MODIFIED RADICAL; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; RADIATION PNEUMONITIS; RADIODERMATITIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT;

EID: 0036280485     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4741.2002.08306.x     Document Type: Conference Paper

References (15)

1. Docetaxel enhances tumor radioresponse in vivo
2. Paclitaxel as a radiosensitizer: A proposed schedule of administration based on in vitro data and pharmacokinetic calculations
3. Lack of radiosensitization after paclitaxel treatment of three human carcinoma cell lines
4. Daily paclitaxel and thoracic radiation therapy for non-small cell lung cancer: Preliminary results
5. Improved disease free and overall survival from the addition of sequential paclitaxel but not from the escalation of doxorubicin dose level in the adjuvant chemotherapy of patients with node-positive primary breast cancer
6. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer
7. Mammographic, pathologic, and treatment-related factors associated with local recurrence in patients with early-stage breast cancer treated with breast conserving therapy
8. Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in highrisk breast cancer
9. Concurrent paclitaxel and radiation therapy for breast cancer
10. Paclitaxel and concurrent radiotherapy in locally advanced non-small cell lung cancer: The Canadian experience
11. Single-agent paclitaxel and radiation for non-small cell lung cancer
12. Seven-week continuous-infusion paclitaxel concurrent with radiation therapy for locally advanced non-small cell lung and head and neck cancers
13. Adriamycin: A possible indirect radiosensitizer of hypoxic tumor cells
14. Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project
15. Long term results with breast-conserving therapy for patients with early stage breast carcinoma in a community hospital setting